HIT

Health In Tech Inc. Class A Common Stock (HIT)

Stock · NASDAQ · Finance

$0.652as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

Health In Tech Unveils HitRix AI Platform and Raises FY26 Revenue Forecast. Health In Tech announced the launch of HitRix, an AI‑powered platform aimed at modernizing the nearly $1 trillion U.S. self‑funded health insurance market. The company also updated its full‑year 2026 revenue guidance to about $33 million. The move signals a shift toward technology‑driven solutions in the health‑insurance space and may influence investor perception of the company’s growth prospects.

Active signals

Resistance level
$0.96075
Industry
Specialty Insurers

What HIT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike10-11.9%20%
Bollinger Band Breakdown6-13.0%17%
Bollinger Band Breakout3-11.1%33%
Any 20-session window (baseline)-9.5%37%

Computed by MarketWall from daily closing prices since October 10, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About HIT

Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative func…

Sector
Finance
Industry
Specialty Insurers
Employees
87

Fundamentals

1-day range
$0.615$0.6519
Market cap
$73.43M
P/E (trailing)
—
P/E (forward)
-31.44
EPS (trailing)
$-0.07
Dividend yield
—
Beta
0.57
Avg. volume
175.1K
52-week range
$0.6301$3.54
Next earnings: November 9, 2026 · EPS estimate $-0.04confirmed

How Health In Tech Inc. Class A Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$19.49MNet Income$670.5K (3%)SG&A$11.64M (60%)Cost of Revenue$4.05M (21%)R&D$2.81M (14%)Tax$218.5K (1%)Other$100.9K (1%)HIT

Source: 10-K filed Mar 17, 2025 · via SEC EDGAR / Finnhub

Gross Profit$15.44M(79%)

Forecasts

3 analyst ratings

Buy 83%
Hold 17%
Sell 0%
1-year price forecast
High
$4.1
+528.8%
Median
$4
+513.5%
Low
$1.25
+91.7%

Health In Tech Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • HIT
    Health In Tech Inc. Class A Common Stock
    $0.652
    ▲ 3.66%
    Market cap $73.43MP/E —
    $0.6301$3.54
  • XHG
    XChange TEC.INC American Depositary Shares
    $2
    ▲ 18.34%
    Market cap $49.07MP/E Infinity
    $0.6501$7.23
  • EHTH
    eHealth Inc. Common Stock
    $0.59
    ▼ 3.28%
    Market cap $42.85MP/E 0.71
    $0.5949$5.89
  • RDZN
    Roadzen Inc. Ordinary Shares
    $1.03
    ▲ 0.00%
    Market cap $104.86MP/E 7.19
    $0.982$2.56
  • CCG
    Cheche Group Inc. Class A Ordinary Shares
    $4.8
    ▼ 4.67%
    Market cap $33.32MP/E —
    $4.11$38.15
  • SLQT
    SelectQuote Inc. Common Stock
    $0.324
    ▼ 4.71%
    Market cap $120.30MP/E 0.98
    $0.32$2.22
  • HUIZ
    Huize Holding Limited American Depositary Shares
    $1.73
    ▲ 20.98%
    Market cap $12.23MP/E 3.62
    $1.04$4.05

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
52.6K
Disposed
301.8K

Institutional Ownership

March 31, 2026

Total shares held
2.46M
Total value held
$3.57M
Institutional holders
14
Top holders this quarter
  • Unknown806.5K
  • Unknown565.5K
  • Unknown373.3K
  • Unknown284.7K
  • Unknown183.3K
  • Unknown62.9K
  • Unknown52.3K
  • Unknown36.6K
  • Unknown36.1K
  • Unknown24.9K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.